In vivo imaging of enzyme conversion of [18F]-Big ET-1 to [18F]-ET-1 and inhibition of enzyme activity using phosphoramidon -: A positron emission tomography study

被引:0
|
作者
Johnström, P
Richards, HK
Fryer, TD
Barret, O
Clark, JC
Pickard, JD
Davenport, AP
机构
[1] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Addenbrookes Ctr Clin Invest, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Clin Pharmacol Unit, Cambridge CB2 2QQ, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
57P
引用
收藏
页码:U29 / U29
页数:1
相关论文
共 50 条
  • [31] [18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis
    Nishiyama, Yoshihiro
    Yamamoto, Yuka
    Dobashi, Hiroaki
    Kameda, Tomohiro
    Satoh, Katashi
    Ohkawa, Motoomi
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2007, 31 (03) : 381 - 383
  • [32] A reactivity-based [18F]FDG probe for in vivo formaldehyde imaging using positron emission tomography
    Liu, Wei
    Truillet, Charles
    Flavell, Robert R.
    Brewer, Thomas F.
    Evans, Michael J.
    Wilson, David M.
    Chang, Christopher J.
    CHEMICAL SCIENCE, 2016, 7 (08) : 5503 - 5507
  • [33] Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT
    Weinstein, Jodi J.
    Moeller, Scott J.
    Perlman, Greg
    Gil, Roberto
    Van Snellenberg, Jared X.
    Wengler, Kenneth
    Meng, Jiayan
    Slifstein, Mark
    Abi-Dargham, Anissa
    BIOLOGICAL PSYCHIATRY, 2024, 96 (05) : 352 - 364
  • [34] Is 18F Fluorodeoxyglucose Positron Emission Tomography Useful to Assess Activity of Myositis?
    Pipitone, Nicolo
    Versari, Annibale
    Salvarani, Carlo
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 91 - 92
  • [35] Imaging Follicular Lymphoma Using Positron Emission Tomography With [18F]Fluorodeoxyglucose: To What Purpose?
    Barrington, Sally F.
    Mikhaeel, N. George
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) : 4285 - 4287
  • [36] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    Barthel, H
    Wilson, H
    Collingridge, DR
    Brown, G
    Osman, S
    Luthra, SK
    Brady, F
    Workman, P
    Price, PM
    Aboagye, EO
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2232 - 2242
  • [37] In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
    H Barthel
    H Wilson
    D R Collingridge
    G Brown
    S Osman
    S K Luthra
    F Brady
    P Workman
    P M Price
    E O Aboagye
    British Journal of Cancer, 2004, 90 : 2232 - 2242
  • [38] Monitoring Sorafenib Resistance and Efficacy in Hepatocellular Carcinoma Using [18F]Alfatide II and [18F]Fluorodeoxyglucose Positron Emission Tomography
    Wang, Guanyun
    Pan, Yue
    Zheng, Lingling
    Zhang, Xiaojun
    Liu, Huanhuan
    Xu, Yanfeng
    Zhang, Wenwen
    Luan, Xiaohui
    Liu, Xiaojie
    Xu, Xiaodan
    Wu, Shina
    Ma, Guangyu
    Kan, Ying
    Zhang, Jinming
    Wang, Ruimin
    Yang, Jigang
    MOLECULAR PHARMACEUTICS, 2025,
  • [39] In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine - A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)
    Ludwig, Friedrich-Alexander
    Fischer, Steffen
    Houska, Richard
    Hoepping, Alexander
    Deuther-Conrad, Winnie
    Schepmann, Dirk
    Patt, Marianne
    Meyer, Philipp M.
    Hesse, Swen
    Becker, Georg-Alexander
    Zientek, Franziska Ruth
    Steinbach, Joerg
    Wuensch, Bernhard
    Sabri, Osama
    Brust, Peter
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
    Jensen, Mette Munk
    Erichsen, Kamille Dumong
    Johnbeck, Camilla Bardram
    Bjorkling, Fredrik
    Madsen, Jacob
    Jensen, Peter Buhl
    Sehested, Maxwell
    Hojgaard, Liselotte
    Kjaer, Andreas
    BMC CANCER, 2013, 13